Meiji Holdings Co Ltd (JP:2269)
:2269
Want to see JP:2269 full AI Analyst Report?
2269 Stock Chart & Stats
¥3033.00
-¥28.00(-0.88%)
At close: 4:00 PM EST
¥3033.00
-¥28.00(-0.88%)
Day’s Range― - ―
52-Week Range¥2,907.00 - ¥4,077.00
Previous CloseN/A
Volume1.14M
Average Volume (3M)2.77M
Market Cap
¥1.02T
Enterprise Value¥1.06T
Total Cash (Recent Filing)¥69.25B
Total Debt (Recent Filing)¥112.58B
Price to Earnings (P/E)28.8
Beta0.10
Next Earnings
Aug 11, 2026EPS Estimate
53.09Next Dividend Ex-DateN/A
Dividend Yield2.96%
Share Statistics
EPS (TTM)129.42
Shares Outstanding282,200,000
10 Day Avg. Volume1,647,740
30 Day Avg. Volume2,774,413
Financial Highlights & Ratios
PEG Ratio-0.98
Price to Book (P/B)1.35
Price to Sales (P/S)0.89
P/FCF Ratio-22.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)230.27
Revenue Forecast (FY)¥1.21T
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelMeiji's dual focus on consumer food (dairy, confectionery, nutrition) and pharmaceuticals provides durable revenue diversification. That breadth smooths demand cycles, enables cross-segment capital allocation and reduces single-market dependency, supporting steadier medium-term cash generation and strategic optionality.
Steady Revenue GrowthConsistent low-to-mid single-digit top-line growth over multiple years signals resilient product demand and market penetration. Stable revenue trends support scale economics, underwriting continued investment in brands and R&D and helping the company better absorb cost shocks over the next several quarters.
Historically Conservative Balance SheetA history of conservative leverage and rising equity through 2021–2025 provides a financial buffer. Even with recent debt increases, the prior capital build gives the company room to fund operations or opportunistic investments without immediate solvency pressure, preserving strategic flexibility.
Bears Say
Profitability DeteriorationA material net income decline and margin compression in 2026 point to persistent profitability headwinds—whether cost inflation, price mix shifts, or product margin erosion. If margins don’t recover, long-term returns on invested capital and the ability to self-fund growth or dividends will be impaired.
Weakened Cash GenerationThe swing to meaningfully negative free cash flow undermines the firm’s capacity to internally fund capex, product investment or shareholder returns. Prolonged negative FCF increases reliance on external financing, raising execution risk for strategic initiatives and constraining resilience to shocks.
Rising Debt In 2026A notable increase in total debt in 2026 elevates leverage risk at a time of weaker earnings and cash flow. If higher indebtedness persists, it will reduce financial flexibility, increase interest exposure and limit the company's ability to invest or navigate adverse industry cycles without materially higher financing costs.
Meiji Holdings Co News
2269 FAQ
What was Meiji Holdings Co Ltd’s price range in the past 12 months?
Meiji Holdings Co Ltd lowest stock price was ¥2907.00 and its highest was ¥4077.00 in the past 12 months.
What is Meiji Holdings Co Ltd’s market cap?
Meiji Holdings Co Ltd’s market cap is ¥1.02T.
When is Meiji Holdings Co Ltd’s upcoming earnings report date?
Meiji Holdings Co Ltd’s upcoming earnings report date is Aug 11, 2026 which is in 57 days.
How were Meiji Holdings Co Ltd’s earnings last quarter?
Meiji Holdings Co Ltd released its earnings results on May 14, 2026. The company reported -¥13.82 earnings per share for the quarter, missing the consensus estimate of ¥3.344 by -¥17.164.
Is Meiji Holdings Co Ltd overvalued?
According to Wall Street analysts Meiji Holdings Co Ltd’s price is currently Overvalued.
Does Meiji Holdings Co Ltd pay dividends?
Meiji Holdings Co Ltd pays a Semiannually dividend of ¥55 which represents an annual dividend yield of 2.96%. See more information on Meiji Holdings Co Ltd dividends here
What is Meiji Holdings Co Ltd’s EPS estimate?
Meiji Holdings Co Ltd’s EPS estimate is 53.09.
How many shares outstanding does Meiji Holdings Co Ltd have?
Meiji Holdings Co Ltd has 282,200,000 shares outstanding.
What happened to Meiji Holdings Co Ltd’s price movement after its last earnings report?
Meiji Holdings Co Ltd reported an EPS of -¥13.82 in its last earnings report, missing expectations of ¥3.344. Following the earnings report the stock price went down -0.609%.
Which hedge fund is a major shareholder of Meiji Holdings Co Ltd?
Currently, no hedge funds are holding shares in JP:2269
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Meiji Holdings Co Ltd
Meiji Holdings Co., Ltd., established in Tokyo, Japan, in 1916, operates globally as a prominent manufacturer and seller across two core business segments: Food and Pharmaceutical. Its extensive Food division produces and markets a wide array of products, including various dairy items like yogurts, milk, cheeses, butter, and ice cream. This segment also encompasses a diverse selection of confectioneries, such as chocolates, gummy treats, and candies, alongside nutritional offerings like sports supplements, infant formulas, and beauty aids. Further contributions from the Food sector include frozen foods, sugar, over-the-counter medications, and livestock products, complemented by essential transportation and distribution services. The Pharmaceutical segment is dedicated to the development and provision of human health solutions, specifically targeting infectious diseases and central nervous system disorders, as well as manufacturing generic drugs, human and animal vaccines, and blood plasma products. Additionally, this division supplies a comprehensive range of veterinary medicines for livestock, fisheries, and companion animals, covering antimicrobials, pain relief, anti-inflammatory agents, and specialized treatments, alongside agricultural and livestock chemicals.
Technical Analysis
Ajinomoto Co
―
Kewpie Corporation
―
Ezaki Glico Co., Ltd.
―
Morinaga Milk Industry Co., Ltd.
―
MEGMILK SNOW BRAND Co., Ltd.
―
Options Prices
Currently, No data available
---